Nathan R. Zuniga

Nathan R. Zuniga

Auto-generated profile, based on publicly available information

Nathan R. Zuniga

Department of Cell Biology, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Journal of Proteome Research
Verified
Journal Article
Closed access
NZNathan R. Zuniga
Nathan R. Zuniga
DFDustin C. Frost
Dustin C. Frost
KKKarsten Kuhn
Karsten Kuhn
MSMyungsun Shin
Myungsun Shin
RWRebecca L. Whitehouse
Rebecca L. Whitehouse
Joao A PauloJoao A Paulo
Joao A Paulo

12 December 2024 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
NZNathan R Zuniga
Nathan R Zuniga
NENoah E Earls
Noah E Earls
ADAriel E A Denos
Ariel E A Denos
JEJared M Elison
Jared M Elison
BJBenjamin S Jones
Benjamin S Jones
JPJohn C Price
John C Price
Apolipoprotein E (ApoE) polymorphisms modify the risk of Alzheimer’s disease with ApoE4 strongly increasing and ApoE2 modestly decreasing risk relative to the control ApoE3. To investigate how ApoE isoforms alter risk, we measured changes in proteome homeostasis in transgenic mice expressing a human ApoE gene (isoform 2, 3, or 4). The regulation of each protein’s homeostasis is observed by measuring turnover rate and abundance for that protein. We identified 4849 proteins and tested for ApoE isoform-dependent changes in the homeostatic regulation of ~2700 ontologies. In the brain, we found that ApoE4 and ApoE2 both lead to modified regulation of mitochondrial membrane proteins relative to the wild-type control ApoE3. In ApoE4 mice, lack of cohesion between mitochondrial membrane and matrix proteins suggests that dysregulation of proteasome and autophagy is reducing protein quality. In ApoE2, proteins of the mitochondrial matrix and the membrane, including oxidative phosphorylation complexes, had a similar increase in degradation which suggests coordinated replacement of the entire organelle. In the liver we did not observe these changes suggesting that the ApoE-effect on proteostasis is amplified in the brain relative to other tissues. Our findings underscore the utility of combining protein abundance and turnover rates to decipher proteome regulatory mechanisms and their potential role in biology. We present a method to quantify and compare in vivo regulation of protein synthesis and degradation for thousands of individual proteins. Using this method, we compare the impact of ApoE isoforms which are known to bias the risk for Alzheimer’s disease. We saw a pattern of changes that links together many published observations in a systematic way to identify biochemical trends increasing the risk of Alzheimer’s disease.

16 September 2025 in bioRxiv
Verified
Preprint
Open access
SSSteven R. Shuken
Steven R. Shuken
GFGeordon A. Frere
Geordon A. Frere
CBCharlotte R. Beard
Charlotte R. Beard
JCJesse D. Canterbury
Jesse D. Canterbury
NZNathan R. Zuniga
Nathan R. Zuniga
QYQing Yu
Qing Yu
The GoDig platform enables sensitive, multiplexed targeted pathway proteomics without manual scheduling or synthetic standards. Here we present GoDig 2.0, which increases sample multiplexing to 35-fold, improves time efficiency and reduces scan delays for higher success rates, and allows flexible spectral and elution library generation from different mass spectrometry data types. GoDig 2.0 measures 2.4× more targets than GoDig 1.0, quantifying >99% of 800 peptides in a single run. We compiled a library of 23,989 human phosphorylation sites from a phosphoproteomic dataset and used it to profile kinase signaling differences across cell lines. In human brain tissue, we established a hyperphosphorylated tau assay including pTau127, revealing potential biomarkers for Alzheimer’s disease. We also quantified diglycyl-lysine peptides to assess polyubiquitin branching. Finally, we built a library of 20,946 reactive cysteines and profiled covalent compound-protein interactions spanning diverse pathways. GoDig 2.0 enables high-throughput analyses of site-specific protein modifications across many biological contexts.

21 April 2025 in Proteomics
Verified
Journal Article
Closed access
SPSneha Parmar
Sneha Parmar
NZNathan R. Zuniga
Nathan R. Zuniga
VRValentina Rossio
Valentina Rossio
XLXinyue (Sherry) Liu
Xinyue (Sherry) Liu
Joao A PauloJoao A Paulo
Joao A Paulo